ARCHIVES

Shubik Group Finally Completes Document On Carcinogenicity Criteria

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

NCI Awards 41.5 Million for DES Study

February 28, 1975

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992

Medicare’s 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR

June 18, 2010

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006